IRCT2013040812938N1已完成未知
Comparison of efficacy of short-acting insulin (Regular) manufactured by Ronak Daru (Ronulin ®) with manufactured by Exir (Lansulin®) in reducing blood sugar after meals in patients with type 2 diabete
Ronak Daru Company of pharmacy0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •inclusion criteria: 1-diabetic patients type 2 treated with insulin with or without oral drug. 2-100mg/dl< FBS <250mg/dl. 3-7< HbA1c< 9. 4-male or female with age > 18 years old*. 5-BMI=30 kg/m2. *We have enrolled patients with age more than 18 years, according to reference 17, 18, 19, and 20.Age don’t be considered as a confounding factor because study has randomized design.
- •exclusion criteria: 1- microvascular and macrovascular complications. 2-hypoglycemia(BS<45mg/dl) or hyperglycemia(BS>250mg/dl). 3-pregnancy or Breastfeeding. 4- use of glucocorticoides or any drug that lead hyperglycemia. 5- uncontrolled HTN (BP>180/105). 6-iinsulin allergy. 7-use of more than 1.4 U/kg/d insulin. 8-????? Cr>2 mg/dl or LFT>twofold normal range. 9-Patient withdrew from the study.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
PH Insulin efficacy in diabetes managementDiabetes mellitusIRCT2013040912938N2Ronak Daru Company of pharmacy196
招募中
不适用
Comparison between long acting insulin analogue and biphasic insulin aspart30/70 (BIAsp 30) as combination therapy with oral anti-diabetic agents.Patients with type 2 diabetes mellitusJPRN-UMIN000005194ational Hospital Organization, Okayama Medical Center30
已完成
不适用
Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomized controlled trialType 2 diabetesJPRN-UMIN000018784Osaka university medical hospital40
招募中
4 期
A study to compare the effectiveness of three different insulin combinations to control blood sugars in patients with type 2 diabetes mellitus in patients admitted to the hospital wards.CTRI/2020/04/024789Sundaram Medical Foundation
已完成
不适用
Clinical Study on rapid-acting insulin analog in intensive basal and bolus insulin therapy ~ Efficacy and safety of glulisine-based multiple daily injection therapy in Japanese diabetic patientsType 1 and type 2 diabetes mellitusJPRN-UMIN000010702Sapporo City Generarl Hospital100